{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T18:48:58Z","timestamp":1790275738736,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[1990,8,1]],"date-time":"1990-08-01T00:00:00Z","timestamp":649468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1990,8,1]],"date-time":"1990-08-01T00:00:00Z","timestamp":649468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[1990,8]]},"DOI":"10.1136\/ard.49.8.587","type":"journal-article","created":{"date-parts":[[2008,7,28]],"date-time":"2008-07-28T23:49:46Z","timestamp":1217288986000},"page":"587-590","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Comparison of the single dose pharmacokinetics of sulphasalazine in rheumatoid arthritis and inflammatory bowel disease."],"prefix":"10.1016","volume":"49","author":[{"given":"C","family":"Astbury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.J","family":"Taggart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Juby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Zebouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.A","family":"Bird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"ref_1","article-title":"handling of the drug","volume-title":"U test.","year":"1989","unstructured":"August 1989 handling of the drug. U test."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1136\/bmj.280.6212.442","article-title":"Sulphasalazine in rheumatoid arthritis","volume":"280","author":"McConkey, B.; Amos, R.; Durham, S.; G, Forster P.J.; Hubball, S.; Walsh, L.","year":"1980","unstructured":"McConkey B, Amos R, Durham S, Forster P J G, Hubball S, Walsh L. Sulphasalazine in rheumatoid arthritis. Br MedJ 1980; 280: 442-4.","journal-title":"Br MedJ"},{"key":"ref_3","first-page":"36","article-title":"A biochemical assessment of sulphasalaine in rheumatoid arthritis","volume":"9","author":"A, Bird H.; S, Dixon J.; E, Pickup M.","year":"1982","unstructured":"Bird H A, Dixon J S, Pickup M E, et al. A biochemical assessment of sulphasalaine in rheumatoid arthritis. J Rhewnatol 1982; 9: 36-45.","journal-title":"J Rhewnatol"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1136\/bmj.287.6399.1099","article-title":"Comparison between penicilimne and sulphasalazine in rheumatoid arthritis: Leeds\/Birmingham trial","volume":"287","author":"C, Neumann V.; A, Grindulis K.; S, Hubball; B, McConkey; V, Wright","year":"1983","unstructured":"Neumann V C, Grindulis K A, Hubball S, McConkey B, Wright V. Comparison between penicilimne and sulphasalazine in rheumatoid arthritis: Leeds\/Birmingham trial. Br Med J 1983; 287: 1099-102.","journal-title":"Br Med J"},{"issue":"1102 4","key":"ref_5","article-title":"Sulphasalazine in rheumatoid arthritis: A double-blind comparison of sulphasalaine with placebo and sodium aurothiomalate","volume":"287","author":"Pullar, T.; A, Hunter J.; A, Capeli J.","year":"1983","unstructured":"Pullar T, Hunter J A, Capeli J A. Sulphasalazine in rheumatoid arthritis: A double-blind comparison of sulphasalaine with placebo and sodium aurothiomalate. BrMedJ 1983; 287: 1102 4.","journal-title":"BrMedJ"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/BF02031270","article-title":"The long term effects of sulphasiazine in the treatment of rheumatoid arthritis and a comparative study with penidillamine","volume":"3","author":"Farr, M.; Tunn, E.; P, Crockson A.; A, Bacon P.","year":"1984","unstructured":"Farr M, Tunn E, Crockson A P, Bacon P A. The long term effects of sulphasiazine in the treatment of rheumatoid arthritis and a comparative study with penidillamine. Clin Rhewlatol 1984; 3: 473-82.","journal-title":"Clin Rhewlatol"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1136\/ard.44.3.194","article-title":"Sulphasalazine: a safe, effective agent for prolonged control ofrheumatoid arthritis. A comparison with sodium aurothiomalate","volume":"44","author":"E, Bax D.; S, Amos R.","year":"1985","unstructured":"Bax D E, Amos R S. Sulphasalazine: a safe, effective agent for prolonged control ofrheumatoid arthritis. A comparison with sodium aurothiomalate. Ann -Rheum Dis 1985; 44: 194-8.","journal-title":"Ann -Rheum Dis"},{"key":"ref_8","first-page":"270","article-title":"Sulphasalazine in severe rheumatoid arthritis: a study to assess potential correlates of efficacy and toxicity","volume":"12","author":"Martin, L.; S, Sitar D.; M, Chalmers I.; HunterT","year":"1985","unstructured":"Martin L, Sitar D S, Chalmers I M, HunterT. Sulphasalazine in severe rheumatoid arthritis: a study to assess potential correlates of efficacy and toxicity. J Rhewmatol 1985; 12: 270-3.","journal-title":"J Rhewmatol"},{"key":"ref_9","first-page":"1427","article-title":"Sulphasalaine in rheumatoid arthritis","volume":"29","author":"S, Pinals R.; B, Kaplan S.; G, Lawson J.; B, Hepburn","year":"1986","unstructured":"Pinals R S, Kaplan S B, Lawson J G, Hepburn B. Sulphasalaine in rheumatoid arthritis. Arthritis Rheun 1986; 29: 1427-34.","journal-title":"Arthritis Rheun"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1136\/ard.43.3.398","article-title":"Outcome of attempts to treat rheumatoid arthritis with gold, penicillamine, sulphasalazine or dapsone","volume":"43","author":"A, Grindulis K.; B, McConkey","year":"1984","unstructured":"Grindulis K A, McConkey B. Outcome of attempts to treat rheumatoid arthritis with gold, penicillamine, sulphasalazine or dapsone. Ann Rhewn Dis 1984; 43: 398-401.","journal-title":"Ann Rhewn Dis"},{"key":"ref_11","first-page":"185","article-title":"Controlled trial of sulphasalaine in maitenance therapy for ulcerative colitus","volume":"i:","author":"J, Kisiewicz J.; E, Lennard-Jones J.; M, Connell A.; H, Baron J.; F, Avery-Jones","year":"1965","unstructured":"Kisiewicz J J, Lennard-Jones J E, Connell A M, Baron J H, Avery-Jones F. Controlled trial of sulphasalaine in maitenance therapy for ulcerative colitus. Lancet 1965; i: 185-8.","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1136\/gut.14.12.923","article-title":"A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphasalaxine (Salazopyrin)","volume":"14","author":"S, Dissanyake A.; C, Truelove S.","year":"1973","unstructured":"Dissanyake A S, Truelove S C. A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphasalaxine (Salazopyrin). Gut 1973; 14: 923-6.","journal-title":"Gut"},{"key":"ref_13","first-page":"232","article-title":"Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis","volume-title":"Gut","volume":"21","author":"K, Azad Khan A.; T, Howes D.; J, Piris; C, Truelove S.","year":"1980","unstructured":"Azad Khan A K, Howes D T, Piris J, Truelove S C. Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis. Gut 1980; 21: 232-40."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/rheumatology\/24.3.269","article-title":"Sulphasalaine in the treatment of rheulmatoid arthritis: Relationship of dose and serum levels to efficacy","volume":"24","author":"Pullar, T.; A, Hunter J.; A, Capell H.","year":"1985","unstructured":"Pullar T, Hunter J A, Capell H A. Sulphasalaine in the treatment of rheulmatoid arthritis: Relationship of dose and serum levels to efficacy. BrJ Rheumatol 1985; 24: 269-76.","journal-title":"BrJ Rheumatol"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3109\/03009748109095308","article-title":"Varying distribution of acetylation phenotypes in RA patients with and without Sjogren's syndrome","volume":"10","author":"Leden, I.; Hanson, A.; Melander, A.; Sturfelt, G.; Svensson, B.; Wahlin-Boll, E.","year":"1981","unstructured":"Leden I, Hanson A, Melander A, Sturfelt G, Svensson B, Wahlin-Boll E. Varying distribution of acetylation phenotypes in RA patients with and without Sjogren's syndrome. Scandj Rhematol 1981; 10: 253-5.","journal-title":"Scandj Rhematol"},{"key":"ref_16","first-page":"706","article-title":"Circulating levels in sulphasalazine and its metabolites and their relation to the clinical efficacy of the drug in ulcerative colitis","volume-title":"Gut","volume":"21","author":"K, Azad Khan A.; C, Truelove S.","year":"1980","unstructured":"Azad Khan A K, Truelove S C. Circulating levels in sulphasalazine and its metabolites and their relation to the clinical efficacy of the drug in ulcerative colitis. Gut 1980; 21: 706-10."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0731-7085(88)80035-9","article-title":"A modified reversed-phase high-performance liquid chromatographic method for the determination of plasma sulphasaline concentrations","volume":"6","author":"Astbury, C.","year":"1988","unstructured":"Astbury C. A modified reversed-phase high-performance liquid chromatographic method for the determination of plasma sulphasaline concentrations. Journal of Pharnacology and Biomedical Analysis 1988; 6: 103-7.","journal-title":"Journal of Pharnacology and Biomedical Analysis"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0378-4347(87)80045-2","article-title":"Rapid method for the determiination of either plasma sulphapyridine or sulphamethoxazole and their acetyl metabolites using high-performance liquid chromatography","volume":"414","author":"Astbury, C.; S, Dixon J.","year":"1987","unstructured":"Astbury C, Dixon J S. Rapid method for the determiination of either plasma sulphapyridine or sulphamethoxazole and their acetyl metabolites using high-performance liquid chromatography. J Chromatogr 1987; 414: 223-7.","journal-title":"J Chromatogr"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1136\/jmg.9.2.168","article-title":"The polymorphic acetylation of sulphapyridine in man","volume":"9","author":"Schroder, H.; A, Price-Evans D.","year":"1972","unstructured":"Schroder H, Price-Evans D A. The polymorphic acetylation of sulphapyridine in man. J Med Genet 1972; 9: 168-71.","journal-title":"J Med Genet"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/gut.13.4.278","article-title":"Acetylator phenotype and adverse effects of sulphasalazine in healthy subjects","volume":"13","author":"Schroder, H.; A, Price-Evans D.","year":"1972","unstructured":"Schroder H, Price-Evans D A. Acetylator phenotype and adverse effects of sulphasalazine in healthy subjects. Gut 1972; 13: 278-84.","journal-title":"Gut"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/cpt1972134539","article-title":"Absorption, metabolism and excretion of salicylaxosulphapyridine in man","volume":"13","author":"Schroder, H.; S, Campbell D.E.","year":"1972","unstructured":"Schroder H, Campbell D E S. Absorption, metabolism and excretion of salicylaxosulphapyridine in man. Clin Pharmacol Ther 1972; 13: 539-55.","journal-title":"Clin Pharmacol Ther"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/gut.20.4.300","article-title":"Influence of intestinal transit time on azo-reduction of salicylazosulphapyridine (Salazopyrin)","volume":"20","author":"P, Van Hees; M, Tuinte J.H.; M, Van Rossum J.; M, Tongeren J.H.","year":"1979","unstructured":"Van Hees P, Tuinte J H M, Van Rossum J M, Tongeren J H M. Influence of intestinal transit time on azo-reduction of salicylazosulphapyridine (Salazopyrin). Gut 1979; 20: 300-4.","journal-title":"Gut"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1096\/fasebj.2.2.3277884","article-title":"Biology of interleukin 1","volume":"2","author":"A, Dinarello C.","year":"1988","unstructured":"Dinarello C A. Biology of interleukin 1. FASEB J 1988; 2: 108-15.","journal-title":"FASEB J"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2362.1982.tb02244.x","article-title":"Serum levels of Creactive protein in Crohn's disease and ulcerative colitis","volume":"12","author":"A, Fagan E.; F, Dyck R.; N, Maton P.","year":"1982","unstructured":"Fagan E A, Dyck R F, Maton P N, et al. Serum levels of Creactive protein in Crohn's disease and ulcerative colitis. Eurj Clin Invest 1982; 12: 351-9.","journal-title":"Eurj Clin Invest"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1136\/bmj.294.6570.483","article-title":"Does sulphoxidation predict gold toxicity in rheumatoid arthritis","volume":"294","author":"Madhok, R.; A, Capell H.; Waring, R.","year":"1987","unstructured":"Madhok R, Capell H A, Waring R. Does sulphoxidation predict gold toxicity in rheumatoid arthritis. Br Med J 1987; 294: 483.","journal-title":"Br Med J"},{"key":"ref_26","first-page":"414","article-title":"Deficient sulphoxidation status and D-penicillamine toxicity","volume":"i:","author":"S, Panayi G.; G, Huston; R, Shah R.","year":"1983","unstructured":"Panayi G S, Huston G, Shah R R, et al. Deficient sulphoxidation status and D-penicillamine toxicity. Lancet 1983; i: 414.","journal-title":"Lancet"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/rheumatology\/26.3.197","article-title":"Sodium aurothiomalate toxicity and sulphoxidation capacity in rheumatoid arthritis patients","volume":"26","author":"Ayesh, R.; C, Mitchell S.; H, Waring R.; H, Withrington R.; H, Seifert M.; L, Smith R.","year":"1987","unstructured":"Ayesh R, Mitchell S C, Waring R H, Withrington R H, Seifert M H, Smith R L. Sodium aurothiomalate toxicity and sulphoxidation capacity in rheumatoid arthritis patients. BrJ Rheumatol 1987; 26: 197-201.","journal-title":"BrJ Rheumatol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724116640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724116640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.49.8.587","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T05:41:07Z","timestamp":1737524467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724116640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,8]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[1990,8]]}},"alternative-id":["S0003496724116640"],"URL":"https:\/\/doi.org\/10.1136\/ard.49.8.587","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[1990,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of the single dose pharmacokinetics of sulphasalazine in rheumatoid arthritis and inflammatory bowel disease.","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.49.8.587","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1990 \u00a9 THE AUTHORS. Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology, EULAR. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}